Physicians are feeling overwhelmed by the demands of practicing medicine generally, but in particular by the demands of the Americans With Disabilities Act of 1990, leading many to experience hesitation when treating people with disabilities, finds a n…
Humana has been anointed the best overall company offering Medicare Advantage plans by U.S. News and World Report, which created an honor roll based on the Centers for Medicare and Medicaid Services newly released Star Ratings for Medicare Advantage Pl…
The Office of Civil Rights is investigating whether pharmacies are not filling prescriptions that could induce a miscarriage, even if the patient is not pregnant.
Elevance Health, formerly known as Anthem, took in $1.6 billion in profit in the third quarter of this year, marking a 7.2% gain from Q3 of 2021. Revenues reached $39.9 billion, up 11.5% from the $35.8 billion in revenue posted a year ago.
President an…
SCAN Health Plan, a Medicare Advantage insurer known for its focus on older adults, is debuting a plan designed for LGBTQ+ seniors, a group the organization claimed has “typically been overlooked and underserved by our healthcare system.”
The plan, SCA…
The Department of Health and Human Services, through the Centers for Medicare and Medicaid Services, has approved Medicaid Section 1115 demonstration initiatives in Arizona that will help the state take aim at health-related social needs.
It’s time to treat mental health on par with physical health, said Health and Human Service Secretary Xavier Becerra, during a news conference announcing millions in state funding and a new crisis care line, 988.
The Department of Justice has filed a civil lawsuit against Cigna and its Medicare Advantage subsidiaries alleging that it sought to boost its reimbursement by submitting false and inaccurate Medicare Advantage diagnostic codes.
Both Humana and CVS reportedly expressed interest in buying primary care provider Cano Health, but on the news that CVS is no longer interested, Cano’s stock plunged by more than 42% by the closing bell on Monday.
President Biden has issued an executive order detailing new payment and delivery models intended to lower the prices of prescription drugs, focusing on models that can be tested under the Center for Medicare and Medicaid Innovation.
